Early-onset hepatic veno-occlusive disease after liver transplantation : an institutional experience and analysis of a literature-based cohort
© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd..
PURPOSE: Hepatic veno-occlusive disease (HVOD) after liver transplantation (LT) is almost always a fatal complication. We assessed the outcomes of HVOD in a single institute and analyzed a literature-based cohort.
METHODS: We reviewed the medical records of recipients of LT performed between 1995 and 2020 at our institute and the literature on HVOD after LT. We then analyzed the clinical features based on a "pooled" cohort of cases identified in our institute and reported in the literature.
RESULTS: HVOD was diagnosed in 3 of 331 LT recipients, all of whom died in hospital, on days 164, 12, and 13, respectively. Our comprehensive review of the literature, as well as our cases, identified eight cases of HVOD that developed within 14 days after LT (early-onset type). Early-onset HVOD had a significantly worse prognosis than HVOD that developed beyond 2 weeks after LT (non-early-onset type), which was identified in 22 cases (25.0% vs. 86.1% of the 3-month graft survival rate). The most common causes of early-onset and non-early-onset types were acute cellular rejection (50%) and drug-induced disease (50%), respectively.
CONCLUSION: Early-onset HVOD developing within 14 days after LT has a poor prognosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Surgery today - (2023) vom: 06. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Endo, Yutaka [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hepatic veno-occlusive disease |
|---|
| Anmerkungen: |
Date Revised 06.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1007/s00595-023-02770-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365460214 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365460214 | ||
| 003 | DE-627 | ||
| 005 | 20231226101720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00595-023-02770-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1218.xml |
| 035 | |a (DE-627)NLM365460214 | ||
| 035 | |a (NLM)38055106 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Endo, Yutaka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early-onset hepatic veno-occlusive disease after liver transplantation |b an institutional experience and analysis of a literature-based cohort |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd. | ||
| 520 | |a PURPOSE: Hepatic veno-occlusive disease (HVOD) after liver transplantation (LT) is almost always a fatal complication. We assessed the outcomes of HVOD in a single institute and analyzed a literature-based cohort | ||
| 520 | |a METHODS: We reviewed the medical records of recipients of LT performed between 1995 and 2020 at our institute and the literature on HVOD after LT. We then analyzed the clinical features based on a "pooled" cohort of cases identified in our institute and reported in the literature | ||
| 520 | |a RESULTS: HVOD was diagnosed in 3 of 331 LT recipients, all of whom died in hospital, on days 164, 12, and 13, respectively. Our comprehensive review of the literature, as well as our cases, identified eight cases of HVOD that developed within 14 days after LT (early-onset type). Early-onset HVOD had a significantly worse prognosis than HVOD that developed beyond 2 weeks after LT (non-early-onset type), which was identified in 22 cases (25.0% vs. 86.1% of the 3-month graft survival rate). The most common causes of early-onset and non-early-onset types were acute cellular rejection (50%) and drug-induced disease (50%), respectively | ||
| 520 | |a CONCLUSION: Early-onset HVOD developing within 14 days after LT has a poor prognosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Hepatic veno-occlusive disease | |
| 650 | 4 | |a Liver transplantation | |
| 650 | 4 | |a Pooled analysis | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Survival rate | |
| 700 | 1 | |a Shinoda, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Maehara, Junki |e verfasserin |4 aut | |
| 700 | 1 | |a Hibi, Taizo |e verfasserin |4 aut | |
| 700 | 1 | |a Hasegawa, Yasushi |e verfasserin |4 aut | |
| 700 | 1 | |a Obara, Hideaki |e verfasserin |4 aut | |
| 700 | 1 | |a Kitago, Minoru |e verfasserin |4 aut | |
| 700 | 1 | |a Ojima, Hidenori |e verfasserin |4 aut | |
| 700 | 1 | |a Tanabe, Minoru |e verfasserin |4 aut | |
| 700 | 1 | |a Kitagawa, Yuko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgery today |d 1997 |g (2023) vom: 06. Dez. |w (DE-627)NLM012623938 |x 1436-2813 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:06 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00595-023-02770-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 06 |c 12 | ||